Keagan G. Moo

The Cyclin-Dependent Kinase 8 (CDK8) Inhibitor DCA Promotes a Tolerogenic Chemical Immunophenotype in CD4+ T Cells via a Novel CDK8-GATA3-FOXP3 Pathway

Kaitlin J. Flynn, R. Xavier, P. Linsley, 2021, Molecular and cellular biology.

The CDK8 inhibitor DCA promotes a tolerogenic chemical immunophenotype in CD4+ T cells via a novel CDK8-GATA3-FOXP3 pathway

Kaitlin J. Flynn, R. Xavier, P. Linsley, 2019, bioRxiv.

The CDK8 inhibitor DCA promotes a tolerogenic chemical immunophenotype in CD4+ T cells via a novel CDK8-GATA3-FOXP3 pathway

Kaitlin J. Flynn, R. Xavier, P. Linsley, 2019, bioRxiv.

Deep immune phenotyping reveals similarities between aging, Down syndrome, and autoimmunity

Kaitlin J. Flynn, P. Linsley, V. Gersuk, 2022, Science Translational Medicine.

Permutational immune analysis reveals architectural similarities between inflammaging, Down syndrome and autoimmunity

Kaitlin J. Flynn, J. Buckner, C. Greenbaum, 2021, bioRxiv.

DCA promotes a novel tolerogenic program in CD 4 + T cells by inhibiting CDK 8

Kaitlin J. Flynn, R. Xavier, P. Linsley, 2019 .